论文部分内容阅读
磷酸羟基哌喹是我校研制的一种抗疟新药。经对大鼠实验性矽肺治疗表明,按100mg/kg体重每周两次的剂量,于病程早期或晚期投药,均有显著的疗效。试治663例矽肺病人结果表明,患者服药后,经线胸片复查,其中153例(占23.07％)显示好转,仅6.49％的病例仍有进展,其余均为稳定。研究证明,本药能减轻病痛,阻止或延缓病程进展,可作为较好的矽肺治疗药物以推广使用。
Hydroxy piperacil is a new anti-malarial drug developed by our school. Experimental silicosis in rats showed that, according to 100mg / kg body weight twice a week dose, early or late course of administration, have a significant effect. The trial of 663 cases of silicosis patients showed that after taking the medicine, the menstrual line chest X-ray examination, of which 153 cases (23.07%) showed improvement, only 6.49% of cases still progress, the rest are stable. Studies have shown that the drug can reduce pain, prevent or delay the progression of the disease, can be used as a good silicosis drug to promote the use.